tirzepatide to retatrutide Difference between and retatrutide: the complete comparison guide Switching from tirzepatide to retatrutide:

In May 2026, Phase 3 topline results from the TRIUMPH-1 trial across 2,339 participants showed an average 28.3 percent body weight reduction over 80 weeks at the highest dose, with 45.3 percent of those participants losing at least 30 percent of body weight a threshold previously achievable only through surgery

Type 2 Diabetes Diagnosis: Fewer participants in the tirzepatide groups were diagnosed with type 2 diabetes compared to the placebo group: Tirzepatide group : 2.4% developed type 2 diabetes

GLP-1 medications reduce thirst signaling alongside hunger signaling, so many patients are already running mildly dehydrated before adding a diuretic on top

Not for human or personal use

John Monroe, offers flu shots and other vaccinations for adult and pediatric patients

16.4 Pediatric Use and Age Restrictions When it comes to kids, we still have a lot to learn about safety and how well medicines work